Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3390 results

Sort By:

The Effect of Therapeutic Play on Anxiety and Fear Levels in Children With Diabetes

Study ID: NCT06418269
Start Date: 2025-07-18
End Date: 2026-08-18
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Therapeutic Play

Sponsor

Istanbul University - Cerrahpasa

Source: clinicaltrials.gov

Share:
Add to list

Management of Acute Tinnitus With Migraine Medications

Study ID: NCT06799169
Start Date: 2025-06
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase4

No. of Participants

100

Intervention / Treatment

Nortriptyline

Topiramate

Paroxetine

Verapamil

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

Mothers' Action Project for Child Health

Study ID: NCT06753669
Start Date: 2025-07-15
End Date: 2028-11-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1260

Intervention / Treatment

health education and social network building

dental referral and educational materials

Sponsor

University of Massachusetts, Worcester

Source: clinicaltrials.gov

Share:
Add to list

Child and Parental Satisfaction of Bioflx Crowns Compared to Zirconia Crowns in Primary Molars

Study ID: NCT06897020
Start Date: 2025-06-01
End Date: 2026-02-26
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

(Group A: Bioflx crowns)

(Group B: Preformed Zirconia crown

Sponsor

Cairo University

Source: clinicaltrials.gov

Share:
Add to list

Biomarker Directed Trial of Temozolomide and PARP Inhibition in Relapsed SCLC

Study ID: NCT06681220
Start Date: 2025-06-01
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

152

Intervention / Treatment

PARP inhibitor/Temozolomide

Lurbinectedin

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Effect of HBOT on Femoral Head Avascular Necrosis (AVN)

Study ID: NCT06931301
Start Date: 2025-06
End Date: 2035-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Hyperbaric Oxygen Therapy

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

Study ID: NCT06943573
Start Date: 2025-06
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

90

Intervention / Treatment

psilocybin (25 mg)

psilocybin 1mg micro-dose

Sponsor

Lakshmi n yatham

Source: clinicaltrials.gov

Share:
Add to list

Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)

Study ID: NCT06586892
Start Date: 2025-10-31
End Date: 2032-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Radiotherapy followed by chemotherapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders

Study ID: NCT06937892
Start Date: 2025-06
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

86

Intervention / Treatment

Transdiagnostic metacognitive therapy

Disorder-specific cognitive-behavioral therapy

Sponsor

Benjamin Bohman

Source: clinicaltrials.gov

Share:
Add to list

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Study ID: NCT05873192
Start Date: 2025-09-30
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

ADT

Enzalutamid

Carcolor

Degarelix

Luprolide

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list